Evaluation of Alcazar Scoring System to Differentiate Between Benign and Malignant Ovarian Masses- A Nepalese Perspective

Authors

  • Rupesh Sharma Lumbini Medical College and Teaching Hospital, Pravas, Palpa, Nepal https://orcid.org/0000-0002-3422-6150
  • Deepak Shrestha Lumbini Medical College and Teaching Hospital, Pravas, Palpa, Nepal https://orcid.org/0000-0002-9006-3640
  • Krishna Thapa Lumbini Medical College and Teaching Hospital, Pravas, Palpa, Nepal
  • Kiran Bhandari Lumbini Medical College and Teaching Hospital, Pravas, Palpa, Nepal

Keywords:

Alcazar scoring system, Doppler, Histopathology, Ovarian mass

Abstract

Introduction: Ovarian cancer is the fifth most common cancer in Nepalese females and the tenth overall, accounting for 5% of the total new cases of cancer in females in 2020. Ultrasonography (USG) remains the primary tool for diagnosis and characterization of ovarian masses in which many grey-scale and Doppler characteristics are evaluated. Various scoring systems have been described incorporating different USG parameters to differentiate benign and malignant nature of the ovarian masses. Alcazar scoring system includes both grey-scale as well as Doppler characteristics of the ovarian masses and is one of the more widely used systems worldwide.

Methods: This was an observational cross-sectional study based on 52 consecutive patients who were clinically suspected to have ovarian mass and referred for USG evaluation and who subsequently underwent surgery.

Results: As confirmed by histopathology, 37 cases were benign and 15 were malignant masses. Alcazar system of scoring identified 34 out of 37 benign cases and 15 out of 15 malignant cases with sensitivity and specificity for diagnosing malignant cases of 83.3% and 91.1% respectively.

Conclusion: Alcazar system of scoring is a highly effective tool to differentiate between benign and malignant ovarian masses and can be of great help in diagnosis, characterization and effective preoperative planning

Downloads

Download data is not yet available.
Abstract
105
PDF
158

Author Biographies

Rupesh Sharma, Lumbini Medical College and Teaching Hospital, Pravas, Palpa, Nepal

Assistant Professor, Department of Radiology

Deepak Shrestha, Lumbini Medical College and Teaching Hospital, Pravas, Palpa, Nepal

Assistant Professor, Department of Obsterics and Gynecology

Krishna Thapa, Lumbini Medical College and Teaching Hospital, Pravas, Palpa, Nepal

Lecturer, Department of Radiology

Kiran Bhandari, Lumbini Medical College and Teaching Hospital, Pravas, Palpa, Nepal

Resident, Department of Radiology

Downloads

Published

2021-12-31

How to Cite

Sharma, R., Shrestha, D., Thapa, K., & Bhandari, K. (2021). Evaluation of Alcazar Scoring System to Differentiate Between Benign and Malignant Ovarian Masses- A Nepalese Perspective. Journal of Lumbini Medical College, 9(2). Retrieved from https://nepjol.info/index.php/JLMC/article/view/47210

Issue

Vol. 9 No. 2 (2021)

Section

Original Research Articles

License

Copyright (c) 2021 Rupesh Sharma, Deepak Shrestha, Krishna Thapa, Kiran Bhandari

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The Journal of Lumbini Medical College (JLMC) publishes open access articles under the terms of the Creative Commons Attribution(CC BY) License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

JLMC requires an exclusive licence allowing to publish the article in print and online.

The corresponding author should read and agree to the following statement before submission of the manuscript for publication,

License agreement
In submitting an article to Journal of Lumbini Medical College (JLMC) I certify that:

  1. I am authorized by my co-authors to enter into these arrangements.
  2. I warrant, on behalf of myself and my co-authors, that:
    • the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
    • I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JLMC are not in breach of any other obligation;
    • the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
    • I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
  3. I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. If the law requires that the article be published in the public domain, I/we will notify JLMC at the time of submission, and in such cases the article shall be released under the Creative Commons 1.0 Public Domain Dedication waiver. For the avoidance of doubt it is stated that sections 1 and 2 of this license agreement shall apply and prevail regardless of whether the article is published under Creative Commons Attribution License 4.0 or the Creative Commons 1.0 Public Domain Dedication waiver.
  4. I, and all co-authors, agree that, if the article is editorially accepted for publication in JLMC, data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.

Please visit Creative Commons web page for details of the terms.